Seer (SEER) Cash from Operations (2020 - 2026)
Seer (SEER) recorded quarterly Cash from Operations of 15435000.0 in Q1 2026, down 42.82% quarter-over-quarter from 10807000.0 in Q4 2025, and down 35.19% on a YoY basis from 23816920.53 in Q1 2025.
Seer (SEER) Cash from Operations (2020 - 2026) Analysis & Trends
Seer's Cash from Operations history runs 7 years deep, the most recent figure standing at 15435000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 35.19% year-over-year to 15435000.0; the TTM figure through Mar 2026 stood at 48466000.0 (down 2.97% YoY), while the FY2025 annual figure was 44448000.0, up 3.6% from the prior year.
- Cash from Operations was 15435000.0 for Q1 2026 at Seer, down from 10807000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 7566000.0 in Q3 2025 to a low of 19331000.0 in Q1 2023.
- Historically, Cash from Operations has averaged 13284529.41 across 5 years, with a median of 14000000.0 in 2022.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations plunged 52.73% in 2022, then soared 46.44% in 2025.
- A 5-year view of Cash from Operations shows it stood at 14256000.0 in 2022, then gained by 28.52% to 10190000.0 in 2023, then slipped by 12.43% to 11457000.0 in 2024, then increased by 5.67% to 10807000.0 in 2025, then slumped by 42.82% to 15435000.0 in 2026.
- The last three Cash from Operations figures came in at 15435000.0 (Q1 2026), 10807000.0 (Q4 2025), and 7566000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Seer | 95.75 Mn | 95.75 Mn | 982,000.00 | -15.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.44 Mn |
| Mar 31, 2026 | -15.44 Mn |
| Dec 31, 2025 | -10.81 Mn |
| Dec 31, 2025 | -10.81 Mn |
| Sep 30, 2025 | -7.57 Mn |
| Sep 30, 2025 | -7.57 Mn |
| Jun 30, 2025 | -14.66 Mn |
| Jun 30, 2025 | -14.66 Mn |
| Mar 31, 2025 | -11.42 Mn |
| Mar 31, 2025 | -11.42 Mn |
| Dec 31, 2024 | -11.46 Mn |
| Dec 31, 2024 | -11.46 Mn |
| Sep 30, 2024 | -14.13 Mn |
| Sep 30, 2024 | -14.13 Mn |
| Jun 30, 2024 | -10.07 Mn |
| Jun 30, 2024 | -10.07 Mn |
| Mar 31, 2024 | -10.46 Mn |
| Mar 31, 2024 | -10.46 Mn |
| Dec 31, 2023 | -10.19 Mn |
| Dec 31, 2023 | -10.19 Mn |